Search Results

You searched for : Zydusnews  

	Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
	Zydus and Bayer announce continuity of their successful Joint Venture Bayer Zydus Pharma has been a successful partnership combining Bayer’s scientific expertise and commercialization of novel products backed by Cadila Healthcare’s strong India ... Jun 22
	Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablet Brivaracetam is used to treat partial-onset of seizures (epilepsy)... Jun 14
	Zydus announces Phase I trials of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor Zydus, today announced that it has received permission to initiate the Phase 1 clinical trial of ZYIL1, a novel oral small molecule NLRP3 inhibitor candidate.... Dec 07
	Zydus announces IND filing of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor NLRP3 inflammasome inhibitor can selectively modulate the inflammatory responses caused by the ‘Cytokine Storm’ in Acute Respiratory Distress Syndrome... Nov 03
	Zydus Cadila receives final approval from USFDA for Albuterol Tablets Albuterol is a bronchodilator and it helps open up the airways in your lungs to make it easier to breathe. ... Oct 23
	Zydus Cadila receives Final Approval from USFDA for Solifenacin Succinate Tablets Zydus Cadila has received final approval from the USFDA to market Solifenacin Succinate Tablets, in the strengths of 5 mg and 10 mg... Oct 21
	Zydus Healthcare launches highly affordable Dapagliflozin tablets in India for the treatment of Type 2 diabetes Zydus Healthcare Limited announced that it is launching the anti-diabetic Dapagliflozin tablets in India upon its patent expiry under the brand name ‘Dapaglyn’... Oct 05
	Zydus Cadila receives tentative approval from USFDA for Palbociclib Capsules Zydus Cadila has received tentative approval from the USFDA to market Palbociclib Capsules, an anti-cancer medicine... Sep 24
9 Matching result(s) found!

Trending Now
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
	100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
	Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
	Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
	High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
	Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
	SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
	Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
	Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
	THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
	Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
	Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
	Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
	Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
	Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
	TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
	AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
	Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026